APOTEA — Apotea AB (publ) Cashflow Statement
0.000.00%
Last trade - 00:00- SEK9.75bn
- SEK10.03bn
- SEK6.54bn
- 84
- 14
- 88
- 71
Annual cashflow statement for Apotea AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 134 | 48.3 | 114 | 266 |
| Depreciation | ||||
| Non-Cash Items | — | — | — | -2.6 |
| Other Non-Cash Items | ||||
| Changes in Working Capital | 44.2 | -86.8 | -10.5 | -187 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 228 | 31.5 | 216 | 206 |
| Capital Expenditures | -81.8 | -142 | -121 | -164 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | -0.1 | 0.7 | -0.5 | 0.1 |
| Acquisition of Business | ||||
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -81.9 | -141 | -122 | -164 |
| Financing Cash Flow Items | -6.6 | -5.1 | -8.7 | -0.5 |
| Other Financing Cash Flow | ||||
| Total Cash Dividends Paid | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -78.7 | 46.3 | -93.3 | -34.2 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 67.6 | -63.6 | 0.9 | 8.3 |